Your session is about to expire
← Back to Search
Behavioral Intervention
Sleep Promotion Intervention for Childhood Sleep Issues
N/A
Waitlist Available
Led By Ayesha Sania, ScD
Research Sponsored by Columbia University
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be younger than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 21 days
Awards & highlights
No Placebo-Only Group
Summary
This trial tests a 3-week behavior sleep intervention for 2-3 year old children in Bangladesh to improve their sleep health.
Who is the study for?
This trial is for healthy children aged 2-3 years who attend early learning centers. It's not suitable for kids with cerebral palsy, severe developmental delays, cardiac disease, autism or those born preterm or with low birthweight.
What is being tested?
The study tests a behavioral sleep intervention called 'Adapted Sleep Well, Bee Well' over three weeks to see if it helps improve sleep in preschoolers compared to children who are on a wait-list at two Early Learning Centers in Dhaka, Bangladesh.
What are the potential side effects?
Since this is a behavioral intervention focusing on improving sleep habits and routines without the use of medication, no direct side effects are anticipated as part of the trial.
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ 21 days
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~21 days
Treatment Details
Study Objectives
Study objectives can provide a clearer picture of what you can expect from a treatment.Primary study objectives
Change in Parental knowledge and beliefs about children's sleep
Intervention feasibility and acceptability
Secondary study objectives
Change in Bedtime Routine
Change in Bedtime Variability
Change in Children's Sleep Duration Variability
+3 moreAwards & Highlights
No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.
Trial Design
2Treatment groups
Experimental Treatment
Active Control
Group I: InterventionExperimental Treatment1 Intervention
Parent questionnaires and sleep characteristics of children (actigraphy and parent report) will be collected at three-time points- Time 1, 2, and 3. Time 1 is the first Baseline Data Collection for the Control Group and Intervention Group, and these data will be collected before the intervention group starts the 3-week intervention. Between Time 1 and Time 2, the Intervention Group will receive the 3-week intervention at the childcare center.
Group II: ControlActive Control1 Intervention
The control arm will not receive the intervention. They will be assessed at time 1 and again at 2, following the completion of intervention in the intervention arm
Find a Location
Who is running the clinical trial?
Columbia UniversityLead Sponsor
1,498 Previous Clinical Trials
2,768,921 Total Patients Enrolled
10 Trials studying Sleep
466 Patients Enrolled for Sleep
New York State Psychiatric InstituteLead Sponsor
479 Previous Clinical Trials
153,770 Total Patients Enrolled
International Centre for Diarrhoeal Disease Research, BangladeshOTHER
306 Previous Clinical Trials
1,417,328 Total Patients Enrolled
Fogarty International Center of the National Institute of HealthNIH
152 Previous Clinical Trials
171,722 Total Patients Enrolled
Ayesha Sania, ScDPrincipal InvestigatorColumbia University
Ayesha Sania, Sc.D.Principal InvestigatorColumbia University
Media Library
Eligibility Criteria:
This trial includes the following eligibility criteria:- My child has a heart condition.My child is healthy, aged 2-3, and goes to an early learning center.My child has a significant developmental delay.My child has autism and was born preterm or with low birthweight.My child has been diagnosed with cerebral palsy.
Research Study Groups:
This trial has the following groups:- Group 1: Intervention
- Group 2: Control
Awards:
This trial has 1 awards, including:- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
Timeline:
This trial has the following timeline:- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.